EAST PROVIDENCE – A local developer of minimally invasive technology for the treatment of bone fractures has raised $11.02 million it hopes will help the company win regulatory approval for its fracture treatment system. The Series B funding should take IlluminOss Medical Inc. “through all of our pre-clinical trial and testing [and] our clinical trial…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.